Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief

This article was originally published in The Tan Sheet

Executive Summary

European trade group touts tradition for herb claims substantiation; Vitacost exits manufacturing; Perrigo launches generic Delsym; Austrian firm offers paper-free blister lid; more news In Brief.

You may also be interested in...



Italy Clears Up Gray Areas Around Use Of Botanicals In Supplements

The Italian Ministry of Health turns its guidelines on the use of botanicals in food supplements into law, making it the second EU country after Belgium to do so, in a market where claims for botanicals are much more rigorously regulated and regularly under fire by the European Food Safety Authority.

Italy Clears Up Gray Areas Around Use Of Botanicals In Supplements

The Italian Ministry of Health turns its guidelines on the use of botanicals in food supplements into law, making it the second EU country after Belgium to do so, in a market where claims for botanicals are much more rigorously regulated and regularly under fire by the European Food Safety Authority.

GNC Leads Supplement Retailers In House Brand Growth

Proprietary products comprise 57% of GNC’s business, up from 40% five years ago, CEO Joseph Fortunato says. Vitamin Shoppe is getting its house brand development capacity off the ground, while Vitacost.com emphasizes the breadth of its proprietary offerings.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS105949

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel